Drugs in Space

Paul Reichert, a research scientist at Merck, tackles the intriguing question of conducting drug research in space to enhance treatments on Earth. He dives into the advantages of crystallization in microgravity, highlighting breakthroughs that could revolutionize oncology drugs. The conversation also touches on the essential qualities of astronauts that contribute to successful experiments. Paul shares humorous anecdotes from recovery operations of space crystals, emphasizing their potential to advance biomedical applications and the innovative technologies shaping the future of space research.